Enanta Pharmaceuticals, Inc. (ENTA)

11.88 -0.12 (-1.00%) USD  |  NASDAQ  |  Sep 25, 16:00
11.88 0.00 (0.00%) After-Hours: 19:59
More

Enanta Pharmaceuticals Cash and Short Term Investments (Annual) : 188.86M for Sept. 30, 2025

Cash and Short Term Investments (Annual) Chart

View Cash and Short Term Investments (Annual) for ENTA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Annual) Chart
Start Trial

Historical Cash and Short Term Investments (Annual) Data

View and export this data back to 2011. Start Trial.
Date Value
September 30, 2025 188.86M
September 30, 2024 248.79M
September 30, 2023 369.91M
September 30, 2022 249.23M
September 30, 2021 244.00M
September 30, 2020 386.65M
September 30, 2019 335.24M
September 30, 2018 308.73M
Date Value
September 30, 2017 223.67M
September 30, 2016 210.08M
September 30, 2015 145.20M
September 30, 2014 90.76M
September 30, 2013 101.48M
September 30, 2012 114.19M
September 30, 2011 24.47M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Annual) Range, Past 5 Years

View Cash and Short Term Investments (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Annual) Benchmarks

View Cash and Short Term Investments (Annual) Benchmarks
Start Trial
Perspective Therapeutics, Inc. 144.74M
Coherus Oncology, Inc. 172.12M
BridgeBio Pharma, Inc. 588.03M
RenovoRx, Inc. 7.024M
ACADIA Pharmaceuticals, Inc. 819.69M